List of works - Lei Huang

A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease

scientific article published on 30 August 2019

Adoptive CD8+ T cell therapy against cancer:Challenges and opportunities

scientific article published on 26 July 2019

An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos.

scientific article published on 16 May 2013

CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint

scientific article published on 24 January 2020

Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1.

scientific article

Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses

scientific article published on 28 August 2013

Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2

scientific article published on 07 December 2021

Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment

scientific article published on 14 September 2020

IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients

scientific article published on 8 November 2017

Immune control by amino acid catabolism during tumorigenesis and therapy

scientific article published on 01 March 2019

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?

scientific article published on 27 October 2017

Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infection

scientific article

Metabolic requirements for expanding and arming a clone army

scientific article published on 01 February 2019

Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity

scientific article published on 01 August 2020

STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation

scientific article published on 10 March 2016

Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase

scientific article

List of works by Lei Huang

A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease

Adoptive CD8+ T cell therapy against cancer:Challenges and opportunities

An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos.

CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint

Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1.

Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses

Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2

Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment

IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients

Immune control by amino acid catabolism during tumorigenesis and therapy

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?

Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infection

Metabolic requirements for expanding and arming a clone army

Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity

STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation

Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase